Commentary Open Access
Volume 2 | Issue 3 | DOI: https://doi.org/10.33696/haematology.2.031
Functional Precision Profiling: The Way Forward for Personalized Medicine
Lyndsey Flanagan1, Siobhan Glavey2,3,*, Triona Ní Chonghaile1
- 1Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland
- 2Department of Pathology, Royal College of Surgeons in Ireland, Dublin, Ireland
- 3Department of Haematology, Beaumont Hospital, Dublin 9, Ireland
Corresponding Author
Siobhan Glavey, siobhanglavey@rcsi.ie
Received Date: April 30, 2021
Accepted Date: May 25, 2021
Flanagan L, Glavey S, Chonghaile TN. Functional Precision Profiling: The Way Forward for Personalized Medicine. J Clin Haematol. 2021; 2(3): 73-79.
Copyright: © 2021 Flanagan L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Long Non-coding RNAs in the Pathophysiology of Multiple Myeloma New Insights on the Role of CRNDE
Over the past 15 years, long non-coding RNAs (lncRNA) have emerged as an important class of regulatory molecules. The currently accepted definition is that lncRNA refers to RNA molecules with little or no protein-coding potential, and which are greater than 200 nucleotides in length, a size cut-off chosen largely to distinguish them from the more-extensively characterised group of small non-coding regulatory RNAs, which includes micro (mi)RNAs, small inhibitory (si)RNAs and PIWI-interacting (pi)RNAs.
The Research Progress of Circular RNA in Multiple Myeloma
The circular RNA (circRNA) is a covalently closed noncoding RNA, recently with the widespread application of high-throughput RNA sequencing bioinformatics methods, a large number of circRNAs found in human cells have been gradually discovered. It performs multiple biological functions in the human body and participates in the occurrence and development of different diseases such as tumors. Studies have found that circRNA is not easily degraded by exonuclease RNase R, has a half-life of more than 48 hours, can stably exist in eukaryotic cells, and its structure is highly conservative and organized, timing, disease-specific, and is expected to become a potential tumor diagnostic marker and therapeutic target.
Therapeutic Monoclonal Antibodies: Future Prospectives
Therapeutic monoclonal antibodies (mAb) have the potential to treat a wide range of various diseases and disorders including cancer, chronic autoimmune and inflammatory diseases, allergies, infections, transplantations, and cardiovascular diseases.
Can Monoclonal Antibodies against CGRP Offer New Treatment Options for Type 2 Diabetes?
The neuropeptide Calcitonin Gene-Related Peptide (CGRP) is a 37-amino acid peptide, with a wide-range of biological activities including vasodilation, neurogenic inflammation, immune function and hypertension. In addition to these various roles, it has also been heavily implicated in metabolic disease, with roles in feeding, energy dissipation processes and pancreatic β-cell insulin secretion.
Current Advances in CAR T Cell Therapy for Malignant Mesothelioma
Malignant mesothelioma (MM) is an incurable primary tumor of the body’s serosal surfaces: the pleura, peritoneum, pericardium and the tunica vaginalis (in men).